Cancer clinical trials in the region Centre-Val de Loire

111 currently recruiting clinical trials
Region Centre-Val de Loire
Phase 3 Multiple myeloma #NCT06918002 #2024-516418-39-00
Symptomatic multiple myeloma Monoclonal component measurable None None Systemic Treatment-Naive
56 recruiting sites
Intergroupe Francophone du Myélome
Phase 3 Multiple myeloma #NCT06152575 #2023-507871-23-00
Symptomatic multiple myeloma Monoclonal component measurable None 1 2 3 or more Monoclonal antibodies Immunomodulator
Systemic Treatment-Naive
13 recruiting sites
Pfizer
Phase 3 Amyloidosis #NCT07052903 #2024-519917-72-00
Other Presence Cardiac
15 recruiting sites
Alnylam Pharmaceuticals
Phase 3 Lung cancer #NCT04613596 #2023-508922-83-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C PDL1 Positive (>= 50%) None Systemic Treatment-Naive
16 recruiting sites
Mirati Thérapeutique Inc.
Phase 3 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Small intestine and appendix cancer #NCT07087054 #2024-519875-24-00
Ileum cancer Neuroendocrine tumor None
6 recruiting sites
Crinetics Pharmaceuticals Inc.
Phase 3 Breast cancer #NCT05512364 #2022-501453-36-00
HER2 Negative HR Positive Localized Locally Advanced None 1 Hormone therapy Surgery Hormone therapy
Systemic Treatment-Naive Systemic Treatment-Naive
14 recruiting sites
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3 Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) #NCT06456346 #2023-505232-36-00
Myeloproliferative neoplasms (MPN) Essential thrombocythemia None Systemic Treatment-Naive
Cytoreductive therapy
8 recruiting sites
Merck Sharp & Dohme LLC